CoChat

A cluster randomised controlled trial, process and economic evaluation of two large-scale quality improvement interventions embedded with a national clinical audit to improve the care for young adults with type 2 diabetes (EQUIPD2): study protocol

Open access

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index; none of the 36 sources its claims cite is checked for support yet.

Abstract

Background: Young adults (18–39 years) with type 2 diabetes have an increased loss of life expectancy and a greater risk of complications such as retinopathy, sexual health problems and foot disease than people diagnosed with type 2 diabetes later in life. Globally, there are increasing numbers of young adults with type 2 diabetes. Evidence describes both care (for example, prescribing) and improvement practices (for example, case management) that improve outcomes for people with type 2 diabetes. The National Diabetes Audit (NDA) provides feedback describing variation in both care and outcomes in young adults. Feedback facilitation can increase the effectiveness of audit feedback. Working collaboratively between researchers, audit providers, patients, clinicians and policy-makers, we have developed two feedback facilitation interventions deliverable at scale across England. We will evaluate whether theory-informed virtual educational materials with email support (low-intensity intervention) and / or virtual workshops (medium-intensity intervention) improve outcomes for young adults with type 2 diabetes. Methods: An efficient, pragmatic cluster randomised controlled trial using routine data with a theory-informed process and economic evaluation. The interventions will be delivered alongside the NDA to primary care networks (small groups of general practices) across England. Our primary outcome will be HbA1c level at 16-months post-randomisation in young adults with type 2 diabetes and baseline HbA1c ≥ 58 mmol/mol. Secondary outcomes assess the proportion with an HbA1c below recommended thresholds, prescription consistent with recommendations and delivery of recommended care processes. We will investigate impacts on equity. We will explore implementation, engagement and fidelity through interviews, observations, documentary analysis and surveys. An economic evaluation will estimate cost-effectiveness and budget impact. Discussion: Our study embeds a further evaluation within the NDA, strengthening its role as a national diabetes learning health system. Our findings will have implications for intervention providers and funders seeking improvement in care and outcomes, and for our understanding of large-scale implementation strategies. Trial registration: ISRCTN 52205353 Registered 12 March 2025. https://www.isrctn.com/ISRCTN52205353 .

Overview

CoChat Summary

TL;DR

EQUIPD2 is a 3-arm cluster randomised trial protocol testing whether low- and medium-intensity feedback facilitation added to National Diabetes Audit feedback improves HbA1c in young adults with type 2 diabetes, alongside process and economic evaluations. It will randomise all 1283 primary care networks in England 1:1:1 and assess HbA1c at 16 months post-randomisation.

Key findings

  • No trial outcome findings are reported; this is a study protocol. The planned primary outcome is HbA1c level at 16 months post-randomisation in young adults (18–39 years) with type 2 diabetes and baseline HbA1c ≥ 58 mmol/mol.
  • Planned sample: all 1283 PCNs in England randomised 1:1:1 to medium-intensity facilitation plus NDA feedback, low-intensity facilitation plus NDA feedback, or NDA feedback alone (waitlist control). Power calculation: 1150 PCNs and 41,365 patients, ICC 0.01, coefficient of variation 1.62, SD 18.7, and 10% loss to follow-up give >99% power to detect a 2 mmol/mol HbA1c difference, using Bonferroni correction.
  • Interventions: medium-intensity facilitation involves 7 virtual workshops; low-intensity facilitation involves asynchronous web-based training with email support; both are delivered by Diabetes UK alongside NDA feedback. Secondary outcomes include HbA1c < 58 mmol/mol, HbA1c < 48 mmol/mol, prescription of metformin and SGLT2 inhibitor, blood pressure ≤ 140/80 mmHg, statin prescription, and NICE-recommended care processes.
  • Process evaluation will use interviews, observations, documentary analysis and surveys; economic evaluation includes within-trial cost-effectiveness and budget impact analyses, a lifetime cost-utility analysis using UKPDS-OM2, and an equity-informative cost-utility analysis.

Methods

  • Design: pragmatic 3-arm cluster randomised controlled trial using routine National Diabetes Audit data, with parallel theory-informed process and economic evaluations; PCNs in England are the clusters, and all PCNs in England are eligible.
  • Randomisation: 1:1:1 using a computer-generated minimisation programme within the Clinical Trials Unit, stratified by PCN-level baseline proportion of young adults with type 2 diabetes and HbA1c ≥ 58 mmol/mol (above or below median) and by NHS Integrated Care Board.
  • Analysis: intention-to-treat; primary outcome compared using mixed effects linear regression with patients nested within PCNs and PCNs as a random intercept, adjusted for patient-level and PCN-level covariates; binary outcomes via mixed effects logistic regression; multiple imputation planned for missing primary outcome; subgroup analyses by ethnicity, sex, age, and deprivation.

Limitations

  • Stated: allocation concealment is not feasible; no interim analyses are planned except for assessment of progression criteria; PCNs cannot give permission for the study because they are not legal entities, so permission is sought from sampled practices.
  • Stated: the process evaluation is limited to up to 60 PCNs, around 20 teams per arm, and observations only in the medium-intensity arm (up to 50% of virtual workshops, approximately 28 h), so process findings may not fully represent all PCNs.
  • Evident: as a protocol, no effectiveness, process, or cost-effectiveness results are yet available; the trial’s power depends on assumptions from 2021–22 NDA data and 10% loss to follow-up.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s13012-025-01479-8

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 CONSORT flow chart
Fig. 1 CONSORT flow chartCC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 30 Not checked · 35 Own results and interpretations

9 more claims

Create a free account to see all 65 claims and to verify the 36 references still open.

See all claims — free account
  • It may state two separate claims as one. 23
  • Probably not a substantial claim. 45

Create a free account to see these claims.

Citations

Cites

Show all 33 references

Cited by

Still being checked.

Metadata

Authors
Sykes, M., Copsey, B., Finch, T., Martin, A., Hankin, A., Girling, M., O’Halloran, E., Medcalf-Bell, R., Dawkins, B., McSharry, J., Morrissey, E., Misra, S., Gable, D., Tan, G., Berry, A., Steele, K., Day, F., Moreau, L., Dewey, R., & Foy, R.
Affiliations
  • Northumbria University (GB)
  • University of Leeds (GB)
  • Ollscoil na Gaillimhe – University of Galway (IE)
  • Imperial College London (GB)
  • Imperial College Healthcare NHS Trust (GB)
  • Diabetes UK (GB)
Corresponding author
Sykes, Michael
Venue
Implementation Science
Published
2026-01-06
Volume
21
Issue
1
Pages
8-8
ISSN
1748-5908 (ISSN-L)
OpenAlex
W7118330863
Cited by
0
References
31
FWCI
0.00
Type
journal article
Language
en
Open access
Licence
Locations
  • Implementation Science (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Health Services Research Programme (168871)
Topics
  • Health Sciences › Health Professions › General Health Professions › Health Policy Implementation Science
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 2 diabetes, young adults, National Diabetes Audit, audit and feedback, quality improvement intervention, HbA1c, glycemic control, drug prescribing, primary care, learning health systems, cost-effectiveness, budget impact, equity, implementation fidelity, email support, online workshops
MeSH terms
Implementation Science, Adolescent, Adult, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, England, Humans, Male, Randomized Controlled Trials as Topic, Clinical Audit, Young Adult, Quality Improvement

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-20, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-20 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A cluster randomised controlled trial, process and economic evaluation of two large-scale quality improvement interventions embedded with a national clinical audit to improve the care for young adults with type 2 diabetes (EQUIPD2): study protocol. https://app.cochat.ai/papers/10.1186/s13012-025-01479-8
The paper
Sykes, M., Copsey, B., Finch, T., Martin, A., Hankin, A., Girling, M., O’Halloran, E., Medcalf-Bell, R., Dawkins, B., McSharry, J., Morrissey, E., Misra, S., Gable, D., Tan, G., Berry, A., Steele, K., Day, F., Moreau, L., Dewey, R., & Foy, R. (2026). A cluster randomised controlled trial, process and economic evaluation of two large-scale quality improvement interventions embedded with a national clinical audit to improve the care for young adults with type 2 diabetes (EQUIPD2): study protocol. Implementation Science. https://doi.org/10.1186/s13012-025-01479-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.